Mark B. Skaletsky

Directeur Général chez Fenway Pharmaceuticals, Inc.

Profil

Mark B. Skaletsky currently works at Fenway Pharmaceuticals, Inc., as Chairman & Chief Executive Officer from 2009, Biotechnology Innovation Organization, as Treasurer, and Bentley University, as Trustee.
Mr. Skaletsky also formerly worked at GelTex Pharmaceuticals, Inc., as President & Chief Executive Officer from 1993 to 2000, Enzytech, Inc., as Chairman & Chief Executive Officer from 1988 to 1993, Althexis Co., Inc., as Chairman & Chief Executive Officer from 2000 to 2001, Trine Pharmaceuticals, Inc., as Chairman & Chief Executive Officer in 2007, Domantis Ltd., as Chairman, Targacept, Inc., as Chairman from 2001 to 2013, Alkermes, Inc., as Lead Independent Director in 2011, ImmunoGen, Inc., as Independent Director from 2011 to 2013, Ionis Pharmaceuticals, Inc., as Director, Cogenics Icoria, Inc., as Director, ABIONYX Pharma SA, as Director, Kiadis Pharma BV, as Director-Supervisory Board, AMAG Pharmaceuticals, Inc., as Director from 2003 to 2009, Alkermes Plc, as Independent Director from 2012 to 2013, and Biogen MA, Inc., as President, Chief Operating & Financial Officer from 1981 to 1988.
Mr. Skaletsky received his undergraduate degree in 1970 from Bentley University.

Postes actifs de Mark B. Skaletsky

Sociétés	Poste	Début
Bentley University	Directeur/Membre du Conseil	-
Biotechnology Innovation Organization	Directeur/Membre du Conseil	-
Fenway Pharmaceuticals, Inc.	Directeur Général	01/05/2008

Anciens postes connus de Mark B. Skaletsky

Sociétés	Poste	Fin
IMMUNOGEN, INC.	Directeur/Membre du Conseil	12/11/2013
Targacept, Inc.	Président	11/11/2013
ALKERMES PLC	Directeur/Membre du Conseil	11/11/2013
Alkermes, Inc.	Directeur/Membre du Conseil	16/09/2011
AMAG PHARMACEUTICALS, INC.	Directeur/Membre du Conseil	31/12/2009